G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (Trilaciclib).
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
3 followers
Gilead Sciences
162 followers
Regeneron
134 followers
Illumina
79 followers
Agilent Technologies
85 followers
Verily Life Sciences
46 followers
Alexion Pharmaceuticals
45 followers
Explore companies